๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase I and pharmacokinetic study of oral thalidomide in patients with advanced hepatocellular carcinoma

โœ Scribed by Her-Shyong Shiah; Yee Chao; Li-Tzong Chen; Tzy-Jyun Yao; Jin-Ding Huang; Jang-Yang Chang; Pei-Jer Chen; Tsai-Rong Chuang; Yung-Hsin Chin; Jacqueline Whang-Peng; Tsang-Wu Liu

Publisher
Springer
Year
2006
Tongue
English
Weight
284 KB
Volume
58
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Phase 2 study of cetuximab in patients w
Phase 2 study of cetuximab in patients with advanced hepatocellular carcinoma
โœ Andrew X. Zhu; Keith Stuart; Lawrence S. Blaszkowsky; Alona Muzikansky; Donald P ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 131 KB ๐Ÿ‘ 1 views

## Abstract ## BACKGROUND. Epidermal growth factor receptor (EGFR) and ligand expression is frequently seen in hepatocellular carcinoma (HCC). A phase 2 study was performed with cetuximab, a chimeric monoclonal antibody that binds specifically to EGFR, in patients with advanced HCC. ## METHODS.